Information

Related Research Units

Immunology Research

Education

Undergraduate School

Union College
1990 Lincoln NE

Medical School

Loma Linda University School of Medicine
1994 Loma Linda CA

Residency

Children's Hospital of Los Angeles
1997 Los Angeles CA

Fellowship

Johns Hopkins University
2000 Baltimore MD

Graduate School

Harvard School of Public Health
2004 Boston MA

Publications

  1. Associations between survey-based thermal comfort, sensor-based indoor temperature, and sleep health in a cross-sectional study of children in Boston, Massachusetts. Sleep Health. 2026 Nov 04. View Abstract
  2. Performance of Generative Artificial Intelligence Models in Answering Common Patient Questions About Nasal Polyps. J Allergy Clin Immunol Pract. 2026 Oct 28. View Abstract
  3. Do School Food Allergy Policies Harm or Help? Quality of Life, Anxiety, and Bullying in Children with Peanut and Tree Nut Allergy. J Allergy Clin Immunol. 2026 Oct 28. View Abstract
  4. Dysregulated NK cell phenotype in exacerbation-prone severe asthma. Eur Respir J. 2026 Oct 11. View Abstract
  5. Ultraviolet irradiation and the home microbiome in childhood asthma: An exploratory environmental analysis. Allergy Asthma Proc. 2026 Nov 01; 47(6):394-398. View Abstract
  6. Effect of IL-4RaR576 polymorphism on response to dupilumab in asthma, a genotype-stratified, randomized, placebo- controlled trial (IDEA trial): design, rationale, methods, strategies, and lessons learned. J Asthma. 2026 Oct 05; 1-14. View Abstract
  7. Allergic Sensitization and Serum Immunoglobulin E in Eosinophilic COPD. Chronic Obstr Pulm Dis. 2026 09 25; 13(5):406-415. View Abstract
  8. Portable HEPA air filtration effects on particulate matter, radioactivity, and chemical constituents in occupied homes. Environ Int. 2026 Oct; 216:110528. View Abstract
  9. Reframing the asthma microbiome: Multikingdom, multisite, and multiomic perspectives. J Allergy Clin Immunol. 2026 Nov; 158(5):1165-1177. View Abstract
  10. Real-world infection outcomes and disparities with dupilumab use in allergic rhinitis. Ann Allergy Asthma Immunol. 2026 Sep 15. View Abstract
  11. Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial. Lancet. 2026 09 19; 408(10560):1103-1113. View Abstract
  12. Classroom microbiome signatures of pest management associate with reduced asthma symptoms. J Allergy Clin Immunol. 2026 Nov; 158(5):1252-1265. View Abstract
  13. Identifying unmet needs in food protein-induced enterocolitis syndrome using search query analysis and a large language model. J Allergy Clin Immunol Glob. 2026 Nov; 5(6):100776. View Abstract
  14. Obesity and allergic diseases in children: childhood asthma as a model for integrated management. Curr Opin Allergy Clin Immunol. 2026 Aug 06. View Abstract
  15. Prevalence and Incidence of Difficult-to-Treat Asthma in Children Between 2010 and 2020: Promise and Pitfalls of Using Routinely Acquired Prescribing Data. J Allergy Clin Immunol Pract. 2026 Nov; 14(11):2595-2603.e4. View Abstract
  16. Sex differences in sleep disturbances in middle childhood: findings from an urban pediatric cohort study. Sleep. 2026 Jul 13; 49(7). View Abstract
  17. Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients. Respir Res. 2026 Jul 10. View Abstract
  18. Dupilumab outcomes in pediatric asthma by early eosinophil status: Post hoc analysis of VOYAGE/EXCURSION. J Allergy Clin Immunol. 2026 09; 158(3):727-738. View Abstract
  19. Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization Level. J Allergy Clin Immunol Pract. 2026 Oct; 14(10):2322-2333.e12. View Abstract
  20. Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures. Allergy. 2026 Sep; 81(9):3130-3145. View Abstract
  21. School district-wide renovations, indoor environmental quality, and illness absence. J Expo Sci Environ Epidemiol. 2026 Nov; 36(6):1221-1228. View Abstract
  22. Associations of rurality, child opportunity, and distance with use of pediatric asthma specialists. J Allergy Clin Immunol. 2026 09; 158(3):751-757. View Abstract
  23. Association of Plasma IL-6 with Indoor Radon Exposure in Children with Non-Allergic Asthma. J Pers Med. 2026 Apr 30; 16(5). View Abstract
  24. Predicting asthma prevalence across US communities by integrating social vulnerability and environmental risk with machine learning. J Allergy Clin Immunol. 2026 09; 158(3):739-750. View Abstract
  25. Stability and age-specific patterns of rhinovirus circulation in children observed over 3 decades. J Allergy Clin Immunol. 2026 Apr 20. View Abstract
  26. The associations between gas cooking stoves, indoor NO2 concentrations, and adverse sleep outcomes in a pediatric sample. Sleep. 2026 Apr 16; 49(4). View Abstract
  27. Allergist impact on anxiety: Findings from a survey of caregivers of patients with food allergy. Ann Allergy Asthma Immunol. 2026 07; 137(1):93-100. View Abstract
  28. Use of a Process Map to Evaluate the Implementation of a Community-Clinical Linked Pediatric Asthma Intervention. Am J Health Promot. 2026 Apr 08; 8901171261441085. View Abstract
  29. Radon and Non-Cancer Pulmonary Health Effects in Children: A State of The Art Review. Pediatr Pulmonol. 2026 Apr; 61(4):e71615. View Abstract
  30. Multi-modal skin atlas identifies a multicellular immune-stromal community associated with disrupted cornification and specific T cell expansion in atopic dermatitis. Nat Commun. 2026 Feb 25; 17(1). View Abstract
  31. Reply: Addressing unmeasured confounding and detection bias in dupilumab-lymphoma association. Eur Respir J. 2026 Feb; 67(2). View Abstract
  32. PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort. J Allergy Clin Immunol. 2026 06; 157(6):1261-1273. View Abstract
  33. Development of Pediatric Dosing for Mepolizumab in Severe Asthma Based on Extrapolation of Data From Adult Patients and a Phase II Open-Label Pediatric Trial. J Clin Pharmacol. 2026 Feb; 66(2):e70155. View Abstract
  34. Nasal microbiome and phageome profiles are associated with prospective respiratory viral infection risk in school-age children. J Allergy Clin Immunol. 2026 08; 158(2):408-420. View Abstract
  35. The definition of asthma remission in children: A scoping review by the WAO Paediatric Asthma Committee. World Allergy Organ J. 2026 Jan; 19(1):101166. View Abstract
  36. The Common Cold Is Associated With Protection From SARS-CoV-2 Infections. J Infect Dis. 2025 Dec 20; 232(6):e920-e930. View Abstract
  37. Associations between reservoir bedroom dust allergen levels and sleep symptoms in school-age children. Sleep Health. 2026 Feb; 12(1):69-77. View Abstract
  38. Fractional Exhaled Nitric Oxide in Eosinophilic COPD. Chronic Obstr Pulm Dis. 2025 Nov 04; 12(6):522-526. View Abstract
  39. IL-4 variant and school mouse exposure increases asthma morbidity in urban schoolchildren. J Allergy Clin Immunol. 2026 Feb; 157(2):543-545. View Abstract
  40. Metabolomic and immunological signatures of asthma severity in children. Pediatr Allergy Immunol. 2025 Nov; 36(11):e70242. View Abstract
  41. Air Purifier Intervention for Respiratory Viral Exposure in Elementary Schools: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2025 10 01; 8(10):e2536951. View Abstract
  42. Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study. Eur Respir J. 2025 Sep; 66(3). View Abstract
  43. S. aureus exposure during cutaneous antigen sensitization causes basophil- and interleukin-4-dependent exaggerated food anaphylaxis. Immunity. 2025 11 11; 58(11):2769-2784.e6. View Abstract
  44. A Pilot Pragmatic Cluster Randomized Trial of School-Supervised Therapy to Improve Pediatric Asthma Control. J Allergy Clin Immunol Pract. 2025 Nov; 13(11):2980-2990.e4. View Abstract
  45. Adjunctive therapy use following Janus kinase inhibitors versus dupilumab in atopic dermatitis. J Allergy Clin Immunol Pract. 2025 Nov; 13(11):3143-3145.e1. View Abstract
  46. Impact of nasal and inhaled corticosteroids on SARS-CoV-2 infection susceptibility. J Allergy Clin Immunol. 2025 Nov; 156(5):1379-1389.e10. View Abstract
  47. Self-Reported Resilience During the COVID-19 Pandemic. JAMA Netw Open. 2025 07 01; 8(7):e2520360. View Abstract
  48. Urbanization and childhood asthma. Pediatr Allergy Immunol. 2025 Jul; 36(7):e70137. View Abstract
  49. Skin levels of toxic shock syndrome toxin-1 predict the severity of atopic dermatitis. J Allergy Clin Immunol. 2025 Aug; 156(2):480-482. View Abstract
  50. Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis. Allergy. 2025 Jun; 80(6):1629-1646. View Abstract
  51. Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence. J Allergy Clin Immunol Pract. 2025 Aug; 13(8):1952-1959. View Abstract
  52. Optimizing Pediatric Asthma Management: Implementation and Evaluation of Anti-Inflammatory Reliever and Single Maintenance and Reliever Therapies. J Allergy Clin Immunol Pract. 2025 07; 13(7):1507-1515. View Abstract
  53. Cost-effectiveness of school integrated pest management and air filtration in students with asthma. Allergy Asthma Proc. 2025 05 01; 46(3):257-266. View Abstract
  54. Indoor Allergen Interventions in Homes and Schools for Managing Asthma. J Allergy Clin Immunol Pract. 2025 06; 13(6):1256-1265. View Abstract
  55. Asthma treatment response modified by fine particulate matter, nitrogen dioxide, and ozone among Black children: A reanalysis of the AsthmaNet Best African American Response to Asthma Drugs trial. J Allergy Clin Immunol. 2025 08; 156(2):330-338. View Abstract
  56. Food allergy-related bullying: Risk factors and psychosocial functioning. Pediatr Allergy Immunol. 2025 Apr; 36(4):e70081. View Abstract
  57. Childhood food allergy and participation in free or reduced-price meal programs at school. J Allergy Clin Immunol Pract. 2025 Jun; 13(6):1481-1484.e2. View Abstract
  58. Maintenance of an Asthma Intervention Post-Trial: Use of a Patient-Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS) Strategy in Black and Latinx Patients. J Am Board Fam Med. 2025 Mar-Apr; 38(2):378-382. View Abstract
  59. Biomarkers of inflammation associated with radon exposure in the School Inner-City Asthma Study (SICAS). J Allergy Clin Immunol. 2025 Jun; 155(6):1866-1872. View Abstract
  60. Vitamin D Supplementation, Long-Term PM2.5 Exposure, and Severe Asthma Exacerbations in Children with Low Vitamin D: A Post Hoc Analysis of a Double-Blind, Randomized, Placebo-controlled Trial (VDKA). Am J Respir Crit Care Med. 2025 Feb; 211(2):266-268. View Abstract
  61. The Impact of the Indoor Environment on Childhood Asthma. Curr Allergy Asthma Rep. 2025 Jan 27; 25(1):11. View Abstract
  62. RELMß sets the threshold for microbiome-dependent oral tolerance. Nature. 2025 02; 638(8051):760-768. View Abstract
  63. Social and environmental determinants of health inequities in childhood asthma. Lancet Respir Med. 2025 Mar; 13(3):197-199. View Abstract
  64. Household Food Allergen Exclusion Practices and Food Allergy-Related Psychosocial Functioning. JAMA Netw Open. 2024 Dec 02; 7(12):e2452646. View Abstract
  65. Caregiver worry about COVID-19 as a predictor of social mitigation behaviours and SARS-CoV-2 infection in a 12-city U.S. surveillance study of households with children. Prev Med Rep. 2025 Jan; 49:102936. View Abstract
  66. Global change, climate change, and asthma in children: Direct and indirect effects - A WAO Pediatric Asthma Committee Report. World Allergy Organ J. 2024 Nov; 17(11):100988. View Abstract
  67. Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial. Respir Med. 2024 Nov-Dec; 234:107853. View Abstract
  68. Venom allergy in hypertrophic cardiomyopathy: When epinephrine could kill. Ann Allergy Asthma Immunol. 2025 Jan; 134(1):102-103. View Abstract
  69. Disparities in pediatric seafood allergy by social determinants of health. J Allergy Clin Immunol Pract. 2025 Jan; 13(1):241-243.e2. View Abstract
  70. Addressing health inequities in pediatric asthma through implementation of school-supervised asthma therapy. J Allergy Clin Immunol Pract. 2025 Jan; 13(1):228-232.e2. View Abstract
  71. Human Epidemiology and Response to SARS-CoV-2 (HEROS): objectives, design, and enrollment results of a 12-city remote observational surveillance study of households with children, using direct-to-participant methods. Am J Epidemiol. 2024 10 07; 193(10):1329-1338. View Abstract
  72. Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome. Allergy. 2025 Feb; 80(2):557-569. View Abstract
  73. Disparities in allergy and asthma prevalence among schoolteachers. J Allergy Clin Immunol. 2025 01; 155(1):223-227. View Abstract
  74. Urinary biomarkers of environmental exposures and asthma morbidity in a school inner city asthma study. Int J Hyg Environ Health. 2024 09; 262:114430. View Abstract
  75. Increasing awareness regarding the relationship between environmental exposures and allergic disease. J Allergy Clin Immunol. 2024 Oct; 154(4):874-881. View Abstract
  76. Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population-based cohort study. Allergy. 2024 10; 79(10):2748-2758. View Abstract
  77. Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: A population-based cohort study. J Allergy Clin Immunol. 2024 Nov; 154(5):1195-1203.e3. View Abstract
  78. Associations between indoor fine particulate matter (PM2.5) and sleep-disordered breathing in an urban sample of school-aged children. Sleep Health. 2025 Aug; 11(4):408-414. View Abstract
  79. An Overview of Adherence-What It Is and Why It Is Important. J Allergy Clin Immunol Pract. 2024 Dec; 12(12):3180-3188. View Abstract
  80. Recommendations for Clinicians to Combat Environmental Disparities in Pediatric Asthma: A Review. Chest. 2024 12; 166(6):1309-1318. View Abstract
  81. Dupilumab 200?mg was efficacious in children (6-11 years) with moderate-to-severe asthma for up to 2 years: EXCURSION open-label extension study. Pediatr Pulmonol. 2024 11; 59(11):2976-2983. View Abstract
  82. Type 2 Inflammation and Asthma in Children: A Narrative Review. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2310-2324. View Abstract
  83. Socioeconomic status is of higher importance than air pollution and environmental factors in childhood asthma prevalence in urban Australia. J Allergy Clin Immunol. 2024 08; 154(2):278-279. View Abstract
  84. Asthma and Sleep-disordered Breathing Overlap in School-aged Children. Ann Am Thorac Soc. 2024 06; 21(6):986-989. View Abstract
  85. Comparison of home-based spirometry and oscillometry measurements in school-age children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2024 10; 59(10):2589-2596. View Abstract
  86. Pediatric asthma comorbidities: Global impact and unmet needs. World Allergy Organ J. 2024 May; 17(5):100909. View Abstract
  87. Exploring the relationship between school-supervised asthma therapy and social determinants of health in pediatric asthma care. Pediatr Pulmonol. 2024 10; 59(10):2553-2562. View Abstract
  88. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma. J Allergy Clin Immunol. 2024 Sep; 154(3):580-591.e6. View Abstract
  89. The effects of urban green space and road proximity to indoor traffic-related PM2.5, NO2, and BC exposure in inner-city schools. J Expo Sci Environ Epidemiol. 2024 09; 34(5):745-752. View Abstract
  90. On mentoring and being mentored-a lifetime journey and legacy. J Allergy Clin Immunol. 2024 06; 153(6):1550-1552. View Abstract
  91. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO. Pediatr Allergy Immunol. 2024 04; 35(4):e14129. View Abstract
  92. A comparison of caregiver-reported snoring and objective snoring in children from urban neighborhoods. Am J Otolaryngol. 2024 Jul-Aug; 45(4):104264. View Abstract
  93. Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study. J Asthma Allergy. 2024; 17:143-159. View Abstract
  94. Basophils are important for development of allergic skin inflammation. J Allergy Clin Immunol. 2024 05; 153(5):1344-1354.e5. View Abstract
  95. Age-specific Metabolomic profiles in children with food allergy. Clin Immunol. 2024 04; 261:109928. View Abstract
  96. Protocol for the air purification for eosinophilic COPD study (APECS): a randomised controlled trial of home air filtration by HEPA. BMJ Open. 2024 01 18; 14(1):e074655. View Abstract
  97. Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy. 2024 05; 79(5):1195-1207. View Abstract
  98. Solar and geomagnetic activity impacts children with asthma. J Allergy Clin Immunol Pract. 2024 04; 12(4):1077-1079.e1. View Abstract
  99. Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma. J Allergy Clin Immunol Pract. 2024 04; 12(4):960-969.e6. View Abstract
  100. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study. J Allergy Clin Immunol Pract. 2024 04; 12(4):948-959. View Abstract
  101. Asthma morbidity measures across Black ethnic subgroups. J Allergy Clin Immunol. 2024 02; 153(2):408-417. View Abstract
  102. Asthma and Environmental Exposures to Phenols, Polycyclic Aromatic Hydrocarbons, and Phthalates in Children. Curr Environ Health Rep. 2023 12; 10(4):469-477. View Abstract
  103. Unanswered questions on the use of biologics in pediatric asthma. World Allergy Organ J. 2023 Nov; 16(11):100837. View Abstract
  104. Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study. Eur Respir J. 2023 11; 62(5). View Abstract
  105. Multi-modal skin atlas identifies a multicellular immune-stromal community associated with altered cornification and specific T cell expansion in atopic dermatitis. bioRxiv. 2023 Oct 31. View Abstract
  106. The spectrum of environmental disparities in asthma. J Allergy Clin Immunol. 2024 02; 153(2):398-400. View Abstract
  107. Multilevel Risk Factors for Sleep-Disordered Breathing-Related Symptom Burden in an Urban Pediatric Community-Based Sample. CHEST Pulm. 2023 Dec; 1(3). View Abstract
  108. Long-Term Exposure to Particulate Matter <2.5 µm and Lung Function Change in Children with Asthma Receiving Inhaled Corticosteroids. Am J Respir Crit Care Med. 2023 09 01; 208(5):622-624. View Abstract
  109. Effects of Allergen Exposure and Environmental Risk Factors in Schools on Childhood Asthma. Curr Allergy Asthma Rep. 2023 10; 23(10):613-620. View Abstract
  110. Future of biologics in pediatric asthma: Optimizing response, early introduction, and equitable access to treatment. Ann Allergy Asthma Immunol. 2024 01; 132(1):13-20. View Abstract
  111. Race-specific spirometry equations may overestimate asthma control in Black children and adolescents. Respir Res. 2023 Aug 17; 24(1):203. View Abstract
  112. High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children. J Allergy Clin Immunol. 2023 12; 152(6):1677-1682. View Abstract
  113. Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization. J Med Virol. 2023 08; 95(8):e29058. View Abstract
  114. Trust, but verify: a new potential association between food allergy and asthma in children. Lancet Child Adolesc Health. 2023 09; 7(9):601-603. View Abstract
  115. Preference for and impact of telehealth vs in-person asthma visits among Black and Latinx adults. Ann Allergy Asthma Immunol. 2023 11; 131(5):614-627.e2. View Abstract
  116. Editorial comment on "Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain". Pediatr Allergy Immunol. 2023 07; 34(7):e13980. View Abstract
  117. Histamine-releasing factor in severe asthma and rhinovirus-associated asthma exacerbation. J Allergy Clin Immunol. 2023 09; 152(3):633-640.e4. View Abstract
  118. Air pollution and human endogenous retrovirus methylation in the school inner-city asthma intervention study. Toxicol Sci. 2023 05 31; 193(2):166-174. View Abstract
  119. Current and Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders. JAMA Netw Open. 2023 05 01; 6(5):e2313120. View Abstract
  120. Effect of radon exposure on asthma morbidity in the School Inner-City Asthma study. Pediatr Pulmonol. 2023 07; 58(7):2042-2049. View Abstract
  121. Pediatric asthma and development of atopy 2023. Curr Opin Allergy Clin Immunol. 2023 04 01; 23(2):98-99. View Abstract
  122. The Fungal Microbiome of the Upper Airway Is Associated With Future Loss of Asthma Control and Exacerbation Among Children With Asthma. Chest. 2023 08; 164(2):302-313. View Abstract
  123. Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma. Ann Allergy Asthma Immunol. 2023 07; 131(1):44-51.e4. View Abstract
  124. The association of objectively measured sedentary time with asthma in US youth: A glimpse into the connection between obesity and asthma. Pediatr Pulmonol. 2023 05; 58(5):1582-1591. View Abstract
  125. Patient Perceptions of Retinal Detachment Management and Recovery through Social Media. Semin Ophthalmol. 2023 Jul; 38(5):498-502. View Abstract
  126. The IL-4Ra Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice. J Allergy Clin Immunol. 2023 05; 151(5):1296-1306.e7. View Abstract
  127. Factors to Consider in Prescribing Asthma Biologic Therapies to Children. J Allergy Clin Immunol Pract. 2023 03; 11(3):693-701. View Abstract
  128. Environment and the development of severe asthma in inner city population. Curr Opin Allergy Clin Immunol. 2023 04 01; 23(2):179-184. View Abstract
  129. Social disparities in early childhood prevention and management of food allergy. J Allergy Clin Immunol. 2023 01; 151(1):37-41. View Abstract
  130. Environmental justice and allergic disease: A Work Group Report of the AAAAI Environmental Exposure and Respiratory Health Committee and the Diversity, Equity and Inclusion Committee. J Allergy Clin Immunol. 2023 03; 151(3):656-670. View Abstract
  131. Utility of biomarkers in the diagnosis and monitoring of asthmatic children. World Allergy Organ J. 2023 Jan; 16(1):100727. View Abstract
  132. Treating asthma in the time of COVID. J Allergy Clin Immunol. 2023 04; 151(4):809-817. View Abstract
  133. Air pollution and childhood asthma. Curr Opin Allergy Clin Immunol. 2023 04 01; 23(2):100-110. View Abstract
  134. A cross-validation based approach for estimating specific gravity in elementary-school aged children using a nonlinear model. Environ Res. 2023 01 15; 217:114793. View Abstract
  135. Association of Asthma With Treatments and Outcomes in Children With Critical Influenza. J Allergy Clin Immunol Pract. 2023 03; 11(3):836-843.e3. View Abstract
  136. Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States. J Allergy Clin Immunol Pract. 2023 04; 11(4):1100-1115. View Abstract
  137. Creating a kinder world for children with food allergies: Lessons from the coronavirus disease 2019 pandemic. Ann Allergy Asthma Immunol. 2022 10; 129(4):397-398. View Abstract
  138. Environmental Exposures Impact Pediatric Asthma Within the School Environment. Immunol Allergy Clin North Am. 2022 11; 42(4):743-760. View Abstract
  139. Environmental radon and childhood asthma. Pediatr Pulmonol. 2022 12; 57(12):3165-3168. View Abstract
  140. The Coronavirus Disease 2019 Pandemic and Mental Health-Related School-Nurse Visits in United States Schools. Acad Pediatr. 2023 04; 23(3):681-685. View Abstract
  141. The Microbiome in Clinical Allergy and Immunology: Emerging Role as Friend and Foe. J Allergy Clin Immunol Pract. 2022 09; 10(9):2252-2253. View Abstract
  142. Determinants of lung function across childhood in the Severe Asthma Research Program (SARP) 3. J Allergy Clin Immunol. 2023 01; 151(1):138-146.e9. View Abstract
  143. The Development of Age-Based Food Allergy Educational Handouts for Caregivers and Patients: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee. J Allergy Clin Immunol Pract. 2022 10; 10(10):2552-2558. View Abstract
  144. Mouse allergen levels in schools over the decade. J Allergy Clin Immunol Pract. 2022 11; 10(11):3024-3025. View Abstract
  145. A common IL-4 receptor variant promotes asthma severity via a Treg cell GRB2-IL-6-Notch4 circuit. Allergy. 2022 11; 77(11):3377-3387. View Abstract
  146. Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant Methods. medRxiv. 2022 Jul 10. View Abstract
  147. Environmental Interventions for Asthma. Semin Respir Crit Care Med. 2022 10; 43(5):720-738. View Abstract
  148. Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design. Am J Epidemiol. 2022 06 27; 191(7):1153-1173. View Abstract
  149. The Environmental Microbiome, Allergic Disease, and Asthma. J Allergy Clin Immunol Pract. 2022 09; 10(9):2206-2217.e1. View Abstract
  150. Cross-sectional study of urinary biomarkers of environmental tobacco and e-cigarette exposure and asthma morbidity. Ann Allergy Asthma Immunol. 2022 09; 129(3):378-380. View Abstract
  151. School Nurse Perspectives on School-Supervised Asthma Therapy: A Qualitative Study. Pediatr Allergy Immunol Pulmonol. 2022 06; 35(2):65-73. View Abstract
  152. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study. J Allergy Clin Immunol. 2022 08; 150(2):302-311. View Abstract
  153. Socioeconomic status associates with worse asthma morbidity among Black and Latinx adults. J Allergy Clin Immunol. 2022 10; 150(4):841-849.e4. View Abstract
  154. Atopic Dermatitis Mediates the Association Between an IL4RA Variant and Food Allergy in School-Aged Children. J Allergy Clin Immunol Pract. 2022 08; 10(8):2117-2124.e4. View Abstract
  155. School-supervised Asthma Therapy is Associated with Improved Long-Term Asthma Outcomes for Underrepresented Minority Children. J Sch Nurs. 2024 08; 40(4):440-445. View Abstract
  156. Violence-related distress and lung function in two longitudinal studies of youth. Eur Respir J. 2022 05; 59(5). View Abstract
  157. Food Allergies in Inner-City Schools: Addressing Disparities and Improving Management. Ann Allergy Asthma Immunol. 2022 10; 129(4):430-439. View Abstract
  158. Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time. Am J Respir Crit Care Med. 2022 05 01; 205(9):1036-1045. View Abstract
  159. Factors Influencing Classroom Exposures to Fine Particles, Black Carbon, and Nitrogen Dioxide in Inner-City Schools and Their Implications for Indoor Air Quality. Environ Health Perspect. 2022 04; 130(4):47005. View Abstract
  160. HEPA filtration intervention in classrooms may improve some students' asthma. J Asthma. 2023 03; 60(3):479-486. View Abstract
  161. CENTER-IT: a novel methodology for adapting multi-level interventions using the Consolidated Framework for Implementation Research-a case example of a school-supervised asthma intervention. Implement Sci Commun. 2022 Mar 26; 3(1):33. View Abstract
  162. The role of environmental allergen control in the management of asthma. World Allergy Organ J. 2022 Mar; 15(3):100634. View Abstract
  163. Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions. Ann Allergy Asthma Immunol. 2022 08; 129(2):169-180. View Abstract
  164. Self-Reported Health Outcomes of Children and Youth with 10 Chronic Diseases. J Pediatr. 2022 07; 246:207-212.e1. View Abstract
  165. Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent Asthma. Ann Am Thorac Soc. 2022 03; 19(3):372-380. View Abstract
  166. Update on indoor allergens and their impact on pediatric asthma. Ann Allergy Asthma Immunol. 2022 06; 128(6):652-658. View Abstract
  167. Social Determinants of Health in Asthma Through the Life Course. J Allergy Clin Immunol Pract. 2022 04; 10(4):953-961. View Abstract
  168. Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA Intern Med. 2022 01 01; 182(1):42-49. View Abstract
  169. The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. J Allergy Clin Immunol. 2022 02; 149(2):488-516.e9. View Abstract
  170. Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. Lancet Child Adolesc Health. 2021 12; 5(12):862-872. View Abstract
  171. Review of efficacy of ciclesonide for the treatment of asthma in children. Allergy Asthma Proc. 2021 11 01; 42(6):461-470. View Abstract
  172. Safety of ciclesonide in children with asthma: A review of randomized controlled trials. Allergy Asthma Proc. 2021 11 01; 42(6):471-480. View Abstract
  173. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. Eur Respir J. 2021 10; 58(4). View Abstract
  174. High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy. Cell Rep Med. 2021 10 19; 2(10):100410. View Abstract
  175. Inhaled Corticosteroid Use in Early Childhood: A Risk for High Body Mass Index? Am J Respir Crit Care Med. 2021 09 15; 204(6):619-620. View Abstract
  176. Indoor Environmental Factors May Modify the Response to Mouse Allergen Reduction Among Mouse-Sensitized and Exposed Children with Persistent Asthma. J Allergy Clin Immunol Pract. 2021 12; 9(12):4402-4409.e2. View Abstract
  177. Effect of School Integrated Pest Management or Classroom Air Filter Purifiers on Asthma Symptoms in Students With Active Asthma: A Randomized Clinical Trial. JAMA. 2021 09 07; 326(9):839-850. View Abstract
  178. Pneumonia in Infancy and Risk for Asthma: Examining the Role of How Viruses Impact Asthma and Potential Interventions. Chest. 2021 08; 160(2):385-386. View Abstract
  179. Food Allergy, Eating Disorders and Body Image. J Affect Disord Rep. 2021 Dec; 6. View Abstract
  180. Incorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy. Contemp Clin Trials. 2021 09; 108:106510. View Abstract
  181. Predictors of successful mouse allergen reduction in inner-city homes of children with asthma. J Allergy Clin Immunol Pract. 2021 11; 9(11):4159-4161.e2. View Abstract
  182. Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank. BMJ Open. 2021 07 02; 11(7):e048338. View Abstract
  183. A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care. Eur Respir J. 2021 07; 58(1). View Abstract
  184. Detection of Food Allergens in School and Home Environments of Elementary Students. J Allergy Clin Immunol Pract. 2021 10; 9(10):3735-3743. View Abstract
  185. Effect of vitamin D supplementation on total and allergen-specific IgE in children with asthma and low vitamin D levels. J Allergy Clin Immunol. 2022 01; 149(1):440-444.e2. View Abstract
  186. Associations of Snoring and Asthma Morbidity in the School Inner-City Asthma Study. J Allergy Clin Immunol Pract. 2021 10; 9(10):3679-3685.e1. View Abstract
  187. Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic. BMJ Open Respir Res. 2021 06; 8(1). View Abstract
  188. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jun; 22(6):794-795. View Abstract
  189. Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate-to-Severe Asthma. Am J Respir Crit Care Med. 2021 04 01; 203(7):841-852. View Abstract
  190. Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection. Am J Respir Crit Care Med. 2021 04 01; 203(7):822-830. View Abstract
  191. Isolation and characterization of extracellular vesicles in saliva of children with asthma. Extracell Vesicles Circ Nucl Acids. 2021; 2:29-48. View Abstract
  192. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort. Allergy. 2021 06; 76(6):1765-1775. View Abstract
  193. The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years. J Allergy Clin Immunol Pract. 2021 07; 9(7):2916-2919.e2. View Abstract
  194. Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design. medRxiv. 2021 Mar 20. View Abstract
  195. PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment. J Allergy Clin Immunol. 2021 05; 147(5):1594-1601. View Abstract
  196. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect. J Allergy Clin Immunol Pract. 2021 03; 9(3):1053-1065. View Abstract
  197. Adherence rates during a randomized controlled trial evaluating the use of blinded acetaminophen and ibuprofen in children with asthma. Contemp Clin Trials. 2021 05; 104:106334. View Abstract
  198. Association of step count with PROMIS pediatric health-related quality of life measures in children and adolescents with persistent asthma. J Allergy Clin Immunol Pract. 2021 06; 9(6):2492-2494. View Abstract
  199. Geography, generalisability, and susceptibility in clinical trials. Lancet Respir Med. 2021 04; 9(4):330-332. View Abstract
  200. The evolution of food protein-induced enterocolitis syndrome: From a diagnosis that did not exist to a condition in need of answers. Ann Allergy Asthma Immunol. 2021 05; 126(5):489-497. View Abstract
  201. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jan; 22(1):100. View Abstract
  202. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemp Clin Trials. 2021 01; 100:106228. View Abstract
  203. Predicting outcomes of baked egg and baked milk oral food challenges by using a ratio of food-specific IgE to total IgE. J Allergy Clin Immunol Pract. 2021 04; 9(4):1750-1752.e1. View Abstract
  204. The United States' reckoning with racism during the COVID-19 pandemic: What can we learn and do as allergist-immunologists? J Allergy Clin Immunol. 2021 02; 147(2):504-506. View Abstract
  205. Asthma Prevalence and Mold Levels in US Northeastern Schools. J Allergy Clin Immunol Pract. 2021 03; 9(3):1312-1318. View Abstract
  206. Editorial overview: Allergy and hypersensitivity - an introduction from the editors. Curr Opin Immunol. 2020 10; 66:vi-viii. View Abstract
  207. Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency. Am J Respir Crit Care Med. 2020 10 01; 202(7):973-982. View Abstract
  208. Screening Social Determinants of Health in a Multidisciplinary Severe Asthma Clinical Program. Pediatr Qual Saf. 2020 Sep-Oct; 5(5):e360. View Abstract
  209. The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations. J Biopharm Stat. 2020 11 01; 30(6):1026-1037. View Abstract
  210. A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2020 11; 21(11):1359-1370. View Abstract
  211. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial. JAMA. 2020 08 25; 324(8):752-760. View Abstract
  212. Maternal Distress and Allergic Disease: Early Childhood Stressors Shape Long-Term Health. Chest. 2020 07; 158(1):5-6. View Abstract
  213. The efficacy of a novel monitoring device on asthma control in children with asthma. Ann Allergy Asthma Immunol. 2020 09; 125(3):352-354. View Abstract
  214. The Psychosocial Impact of Food Protein-Induced Enterocolitis Syndrome. J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3508-3514.e5. View Abstract
  215. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020 09; 8(8):2592-2599.e3. View Abstract
  216. The Indoor Environment and Childhood Asthma. Curr Allergy Asthma Rep. 2020 06 16; 20(9):43. View Abstract
  217. Risk of physician burnout in the North American allergist-immunologist workforce: A report from the American College of Allergy, Asthma and Immunology Physician Wellness Taskforce. Ann Allergy Asthma Immunol. 2020 09; 125(3):235-243. View Abstract
  218. Impact of DNA Extraction Method on Variation in Human and Built Environment Microbial Community and Functional Profiles Assessed by Shotgun Metagenomics Sequencing. Front Microbiol. 2020; 11:953. View Abstract
  219. Differential Effect of School-Based Pollution Exposure in Children With Asthma Born Prematurely. Chest. 2020 10; 158(4):1361-1363. View Abstract
  220. Prevention of Asthma: Targets for Intervention. Chest. 2020 09; 158(3):913-922. View Abstract
  221. Obesity may enhance the adverse effects of NO2 exposure in urban schools on asthma symptoms in children. J Allergy Clin Immunol. 2020 10; 146(4):813-820.e2. View Abstract
  222. Heterogeneity of Mild to Moderate Persistent Asthma in Children: Confirmation by Latent Class Analysis and Association with 1-Year Outcomes. J Allergy Clin Immunol Pract. 2020 09; 8(8):2617-2627.e4. View Abstract
  223. Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank. J Allergy Clin Immunol Pract. 2020 06; 8(6):1953-1960.e9. View Abstract
  224. Allergic Endotypes and Phenotypes of Asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):429-440. View Abstract
  225. A Slice of Food Protein-Induced Enterocolitis Syndrome (FPIES): Insights from 441 Children with FPIES as Provided by Caregivers in the International FPIES Association. J Allergy Clin Immunol Pract. 2020 05; 8(5):1702-1709. View Abstract
  226. Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy. Pediatr Pulmonol. 2020 03; 55(3):580-590. View Abstract
  227. Reduction in mouse allergen exposure is associated with greater lung function growth. J Allergy Clin Immunol. 2020 02; 145(2):646-653.e1. View Abstract
  228. The upper-airway microbiota and loss of asthma control among asthmatic children. Nat Commun. 2019 12 16; 10(1):5714. View Abstract
  229. Nature and nurture: Lifelong consequences of environmental exposures. Ann Allergy Asthma Immunol. 2019 12; 123(6):532-533. View Abstract
  230. Asthma and Allergies in the School Environment. Clin Rev Allergy Immunol. 2019 Dec; 57(3):415-426. View Abstract
  231. The Impact of Ambient Environmental Exposures to Microbial Products on Asthma Outcomes from Birth to Childhood. Curr Allergy Asthma Rep. 2019 11 28; 19(12):59. View Abstract
  232. Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. J Allergy Clin Immunol. 2020 03; 145(3):897-906. View Abstract
  233. Severe asthma during childhood and adolescence: A longitudinal study. J Allergy Clin Immunol. 2020 01; 145(1):140-146.e9. View Abstract
  234. Development and initial validation of the Asthma Severity Scoring System (ASSESS). J Allergy Clin Immunol. 2020 01; 145(1):127-139. View Abstract
  235. Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician. World Allergy Organ J. 2019 Sep; 12(9):100054. View Abstract
  236. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. N Engl J Med. 2019 09 26; 381(13):1227-1239. View Abstract
  237. Proximity to major roadways and asthma symptoms in the School Inner-City Asthma Study. J Allergy Clin Immunol. 2020 01; 145(1):119-126.e4. View Abstract
  238. Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trials. J Allergy Clin Immunol. 2019 12; 144(6):1524-1533. View Abstract
  239. Do Baseline Asthma and Allergic Sensitization Characteristics Predict Responsiveness to Mouse Allergen Reduction? J Allergy Clin Immunol Pract. 2020 02; 8(2):596-602.e3. View Abstract
  240. Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma. J Allergy Clin Immunol. 2020 01; 145(1):430-433. View Abstract
  241. Clinical significance of the bronchodilator response in children with severe asthma. Pediatr Pulmonol. 2019 11; 54(11):1694-1703. View Abstract
  242. Racial and socioeconomic differences in school peanut-free policies. J Allergy Clin Immunol Pract. 2020 01; 8(1):340-342.e1. View Abstract
  243. Deficits and opportunities in allergists' approaches to food allergy-related bullying. J Allergy Clin Immunol Pract. 2020 01; 8(1):343-345.e2. View Abstract
  244. Classroom indoor PM2.5 sources and exposures in inner-city schools. Environ Int. 2019 10; 131:104968. View Abstract
  245. Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma. Am J Respir Crit Care Med. 2019 06 01; 199(11):1358-1367. View Abstract
  246. Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. N Engl J Med. 2019 05 23; 380(21):2009-2019. View Abstract
  247. The Effects of the Environment on Asthma Disease Activity. Immunol Allergy Clin North Am. 2019 05; 39(2):163-175. View Abstract
  248. Preventing the development of asthma: stopping the allergic march. Curr Opin Allergy Clin Immunol. 2019 04; 19(2):161-168. View Abstract
  249. Association between fungal spore exposure in inner-city schools and asthma morbidity. Ann Allergy Asthma Immunol. 2019 06; 122(6):610-615.e1. View Abstract
  250. Building and indoor environmental quality assessment of Nigerian primary schools: A pilot study. Indoor Air. 2019 05; 29(3):510-520. View Abstract
  251. Treatment of severe persistent asthma with IL-6 receptor blockade. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1639-1642.e4. View Abstract
  252. Use of a School-Based Survey to Screen Students for Symptoms Concerning for Asthma. Clin Pediatr (Phila). 2019 05; 58(5):586-589. View Abstract
  253. Asthma and Corticosteroid Responses in Childhood and Adult Asthma. Clin Chest Med. 2019 03; 40(1):163-177. View Abstract
  254. Caregiver-Reported Asthma Control Predicts Future Visits, Independent of Guideline-Based Control Measures. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1516-1521.e1. View Abstract
  255. Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children. J Allergy Clin Immunol. 2019 05; 143(5):1934-1937.e4. View Abstract
  256. Severe asthma in children: Evaluation and management. Allergol Int. 2019 Apr; 68(2):150-157. View Abstract
  257. Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2019 06; 143(6):2052-2061. View Abstract
  258. Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document. Allergy. 2019 03; 74(3):449-463. View Abstract
  259. Asthma in the melting pot. Ann Allergy Asthma Immunol. 2019 02; 122(2):136-139. View Abstract
  260. Pediatric asthma: An unmet need for more effective, focused treatments. Pediatr Allergy Immunol. 2019 02; 30(1):7-16. View Abstract
  261. Environmental Food Exposure: What Is the Risk of Clinical Reactivity From Cross-Contact and What Is the Risk of Sensitization. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):1825-1832. View Abstract
  262. Validation of the maximum symptom day among children with asthma. J Allergy Clin Immunol. 2019 02; 143(2):803-805.e10. View Abstract
  263. Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation. J Allergy Clin Immunol Pract. 2019 03; 7(3):915-924.e7. View Abstract
  264. Bronchodilator Use for Acute Chest Syndrome Among Large Pediatric Hospitals in North America. Clin Pediatr (Phila). 2018 12; 57(14):1630-1637. View Abstract
  265. Taming Asthma in School-Aged Children: A Comprehensive Review. J Allergy Clin Immunol Pract. 2018 May - Jun; 6(3):726-735. View Abstract
  266. Fluid Balance Is Associated with Clinical Outcomes and Extravascular Lung Water in Children with Acute Asthma Exacerbation. Am J Respir Crit Care Med. 2018 05 01; 197(9):1128-1135. View Abstract
  267. School exposure and asthma. Ann Allergy Asthma Immunol. 2018 05; 120(5):482-487. View Abstract
  268. A Community-Based Pilot Survey of Pediatric Food Allergies in a Maryland Orthodox Jewish Community. Clin Pediatr (Phila). 2018 09; 57(10):1236-1238. View Abstract
  269. Transcutaneous CO-oximetry differentiates asthma exacerbation and convalescence in children. J Allergy Clin Immunol. 2018 08; 142(2):676-678.e5. View Abstract
  270. Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma. BMC Pulm Med. 2018 Apr 10; 18(1):58. View Abstract
  271. The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma. Ann Allergy Asthma Immunol. 2018 06; 120(6):559-579.e11. View Abstract
  272. The classroom microbiome and asthma morbidity in children attending 3 inner-city schools. J Allergy Clin Immunol. 2018 06; 141(6):2311-2313. View Abstract
  273. Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation? J Allergy Clin Immunol. 2018 07; 142(1):308-311.e9. View Abstract
  274. Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations. N Engl J Med. 2018 Mar 08; 378(10):891-901. View Abstract
  275. Gene-Environment Interactions Associated with the Severity of Acute Asthma Exacerbation in Children. Am J Respir Crit Care Med. 2018 03 01; 197(5):545-547. View Abstract
  276. Environmental Control: The First Tenet of Allergy. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):36-37. View Abstract
  277. School Environmental Intervention Programs. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):22-29. View Abstract
  278. Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids. J Allergy Clin Immunol. 2018 04; 141(4):1459-1467.e2. View Abstract
  279. Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017 12; 50(6). View Abstract
  280. School nurse asthma program reduces healthcare utilization in children with persistent asthma. J Asthma. 2018 10; 55(10):1131-1137. View Abstract
  281. Advances in environmental and occupational disorders in 2016. J Allergy Clin Immunol. 2017 Dec; 140(6):1683-1692. View Abstract
  282. Nitrogen dioxide exposure in school classrooms of inner-city children with asthma. J Allergy Clin Immunol. 2018 06; 141(6):2249-2255.e2. View Abstract
  283. Gene-environment interaction between an IL4R variant and school endotoxin exposure contributes to asthma symptoms in inner-city children. J Allergy Clin Immunol. 2018 02; 141(2):794-796.e3. View Abstract
  284. Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies. J Allergy Clin Immunol Pract. 2018 May - Jun; 6(3):907-915.e7. View Abstract
  285. Managing Asthma in Low-Income, Underrepresented Minority, and Other Disadvantaged Pediatric Populations: Closing the Gap. Curr Allergy Asthma Rep. 2017 Sep 15; 17(10):68. View Abstract
  286. Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):545-554.e4. View Abstract
  287. Reply. J Allergy Clin Immunol. 2017 10; 140(4):1214-1215. View Abstract
  288. Adherence and stress in a population of inner-city children with asthma. Pediatr Allergy Immunol. 2017 09; 28(6):610-612. View Abstract
  289. Reply. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1165-1166. View Abstract
  290. Distribution of peanut protein in school and home environments of inner-city children. J Allergy Clin Immunol. 2017 12; 140(6):1724-1726. View Abstract
  291. The School Inner-City Asthma Intervention Study: Design, rationale, methods, and lessons learned. Contemp Clin Trials. 2017 09; 60:14-23. View Abstract
  292. Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma. Am J Respir Crit Care Med. 2017 06 01; 195(11):1439-1448. View Abstract
  293. Income is an independent risk factor for worse asthma outcomes. J Allergy Clin Immunol. 2018 02; 141(2):754-760.e3. View Abstract
  294. NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma-implications for home environmental intervention in asthma prevention and management. J Allergy Clin Immunol. 2017 Oct; 140(4):933-949. View Abstract
  295. Reduced mouse allergen is associated with epigenetic changes in regulatory genes, but not mouse sensitization, in asthmatic children. Environ Res. 2017 07; 156:619-624. View Abstract
  296. Caregiver stress among inner-city school children with asthma. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1132-1134.e3. View Abstract
  297. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem. World Allergy Organ J. 2017; 10(1):14. View Abstract
  298. Impact of school peanut-free policies on epinephrine administration. J Allergy Clin Immunol. 2017 Aug; 140(2):465-473. View Abstract
  299. Effect of an Integrated Pest Management Intervention on Asthma Symptoms Among Mouse-Sensitized Children and Adolescents With Asthma: A Randomized Clinical Trial. JAMA. 2017 03 14; 317(10):1027-1036. View Abstract
  300. Reply. J Allergy Clin Immunol. 2017 05; 139(5):1717-1718. View Abstract
  301. Environmental control measures for the management of atopy. Ann Allergy Asthma Immunol. 2017 02; 118(2):154-160. View Abstract
  302. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations. Am J Respir Crit Care Med. 2017 02 01; 195(3):302-313. View Abstract
  303. Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1040-1049.e4. View Abstract
  304. Race is associated with differences in airway inflammation in patients with asthma. J Allergy Clin Immunol. 2017 Jul; 140(1):257-265.e11. View Abstract
  305. The Calculated Risk of Childhood Asthma From Severe Bronchiolitis. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):97-98. View Abstract
  306. Association Between Allergen Exposure in Inner-City Schools and Asthma Morbidity Among Students. JAMA Pediatr. 2017 01 01; 171(1):31-38. View Abstract
  307. Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston. Online J Public Health Inform. 2016; 8(3):e199. View Abstract
  308. Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation. Am J Respir Crit Care Med. 2016 12 15; 194(12):1552-1555. View Abstract
  309. Mouse Sensitization and Exposure Are Associated with Asthma Severity in Urban Children. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1008-1014.e1. View Abstract
  310. Indoor allergen exposure and asthma outcomes. Curr Opin Pediatr. 2016 12; 28(6):772-777. View Abstract
  311. Acetaminophen versus Ibuprofen in Mild Persistent Asthma. N Engl J Med. 2016 11 24; 375(21):2099-100. View Abstract
  312. Comparison of treatment modalities for inpatient asthma exacerbations among US pediatric hospitals. J Allergy Clin Immunol Pract. 2017 May - Jun; 5(3):855-857.e1. View Abstract
  313. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol. 2016 12; 138(6):1608-1618.e12. View Abstract
  314. School Environmental Intervention to Reduce Particulate Pollutant Exposures for Children with Asthma. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):154-159.e3. View Abstract
  315. Modeling indoor particulate exposures in inner-city school classrooms. J Expo Sci Environ Epidemiol. 2017 09; 27(5):451-457. View Abstract
  316. Creation and implementation of SAMPRO™: A school-based asthma management program. J Allergy Clin Immunol. 2016 Sep; 138(3):711-723. View Abstract
  317. Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma. N Engl J Med. 2016 Aug 18; 375(7):619-30. View Abstract
  318. An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells. Nat Med. 2016 09; 22(9):1013-22. View Abstract
  319. Utility of a portable hand-held forced expiratory volume in 1 second meter for monitoring asthma in an inner-city school setting. Ann Allergy Asthma Immunol. 2016 09; 117(3):323-4. View Abstract
  320. Pediatric Rhinosinusitis. Curr Treat Options Allergy. 2016 Sep; 3(3):268-281. View Abstract
  321. Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies. Ann Allergy Asthma Immunol. 2016 07; 117(1):17-20. View Abstract
  322. Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. J Allergy Clin Immunol. 2016 11; 138(5):1467-1471.e9. View Abstract
  323. Association of FEF25%-75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma. Ann Allergy Asthma Immunol. 2016 07; 117(1):97-9. View Abstract
  324. Characterization of the bacterial and fungal microbiome in indoor dust and outdoor air samples: a pilot study. Environ Sci Process Impacts. 2016 Jun 15; 18(6):713-24. View Abstract
  325. Atopy, but not obesity is associated with asthma severity among children with persistent asthma. J Asthma. 2016 12; 53(10):1033-44. View Abstract
  326. Recent advances in environmental controls outside the home setting. Curr Opin Allergy Clin Immunol. 2016 Apr; 16(2):135-41. View Abstract
  327. Procedures to Assist Health Care Providers to Determine When Home Assessments for Potential Mold Exposure Are Warranted. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):417-422.e2. View Abstract
  328. Exposure and Health Effects of Fungi on Humans. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):396-404. View Abstract
  329. An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. Expert Rev Clin Immunol. 2016; 12(5):521-30. View Abstract
  330. Early exposure to dogs and farm animals reduces risk of childhood asthma. Evid Based Med. 2016 Apr; 21(2):80. View Abstract
  331. Clinical Evaluation and Management of Patients with Suspected Fungus Sensitivity. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):405-14. View Abstract
  332. Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. JAMA. 2015 Nov 17; 314(19):2034-2044. View Abstract
  333. School Endotoxin Exposure and Asthma Morbidity in Inner-city Children. Chest. 2015 Nov; 148(5):1251-1258. View Abstract
  334. The school environment and asthma in childhood. Asthma Res Pract. 2015; 1. View Abstract
  335. Mouse Sensitivity is an Independent Risk Factor for Rhinitis in Children with Asthma. J Allergy Clin Immunol Pract. 2016 Jan-Feb; 4(1):82-8.e1. View Abstract
  336. Difficult-to-control asthma: epidemiology and its link with environmental factors. Curr Opin Allergy Clin Immunol. 2015 Oct; 15(5):397-401. View Abstract
  337. Alternate methods of nasal epithelial cell sampling for airway genomic studies. J Allergy Clin Immunol. 2015 Oct; 136(4):1120-3.e4. View Abstract
  338. Black and Hispanic perceptions of asthma medication in the School Inner-City Asthma Study. Ann Allergy Asthma Immunol. 2015 Jun; 114(6):533-4. View Abstract
  339. Year in review: pediatric allergy and asthma, excluding food allergy. Ann Allergy Asthma Immunol. 2015 Mar; 114(3):175-7. View Abstract
  340. Association between allergic sensitization and exhaled nitric oxide in children in the School Inner-City Asthma Study. Ann Allergy Asthma Immunol. 2015 Mar; 114(3):256-257.e1. View Abstract
  341. Effectiveness of a computer module to augment the training of school staff in the management of students with food allergies. Ann Allergy Asthma Immunol. 2015 Mar; 114(3):254-255.e3. View Abstract
  342. Child with atopic dermatitis. Ann Allergy Asthma Immunol. 2015 Jan; 114(1):6-11. View Abstract
  343. Ovomucoid specific immunoglobulin E as a predictor of tolerance to cooked egg. Allergy Rhinol (Providence). 2015 Jan; 6(3):198-204. View Abstract
  344. How mothers and fathers perceive childhood food allergies: comparing apples to oranges? Ann Allergy Asthma Immunol. 2015 Feb; 114(2):77-8. View Abstract
  345. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents. Immunol Allergy Clin North Am. 2015 Feb; 35(1):129-44. View Abstract
  346. Airway and systemic inflammation in obese children with asthma. Pediatrics. 2014 Nov; 134 Suppl 3:S169. View Abstract
  347. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study. Pediatrics. 2014 Nov; 134 Suppl 3:S175-6. View Abstract
  348. Add-on Omalizumab in Children With Severe Allergic Asthma: A 1-Year Real Life Survey. Pediatrics. 2014 Nov; 134 Suppl 3:S179-80. View Abstract
  349. Introducing an environmental assessment and intervention program in inner-city schools. J Allergy Clin Immunol. 2014 Dec; 134(6):1232-1237. View Abstract
  350. Indoor environmental exposures and exacerbation of asthma: an update to the 2000 review by the Institute of Medicine. Environ Health Perspect. 2015 Jan; 123(1):6-20. View Abstract
  351. Reprint of: Perinatal and early childhood environmental factors influencing allergic asthma immunopathogenesis. Int Immunopharmacol. 2014 Nov; 23(1):337-46. View Abstract
  352. Childhood asthma and obesity--what is the true link? Ann Allergy Asthma Immunol. 2014 Sep; 113(3):244-6. View Abstract
  353. Perinatal and early childhood environmental factors influencing allergic asthma immunopathogenesis. Int Immunopharmacol. 2014 Sep; 22(1):21-30. View Abstract
  354. The indoor environment and inner-city childhood asthma. Asian Pac J Allergy Immunol. 2014 Jun; 32(2):103-10. View Abstract
  355. Social disadvantage and asthma control in children. Paediatr Respir Rev. 2014 Sep; 15(3):256-62; quiz 262-3. View Abstract
  356. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014 May; 311(20):2083-91. View Abstract
  357. Reply: To PMID 24290281. J Allergy Clin Immunol. 2014 Jun; 133(6):1776-7. View Abstract
  358. Allergens on desktop surfaces in preschools and elementary schools of urban children with asthma. Allergy. 2014 Jul; 69(7):960-963. View Abstract
  359. Environmental remediation in the treatment of allergy and asthma: latest updates. Curr Allergy Asthma Rep. 2014 Mar; 14(3):419. View Abstract
  360. Intravenous ß agonists and severe pediatric asthma exacerbation: time for a closer look at terbutaline? Ann Allergy Asthma Immunol. 2014 Mar; 112(3):187. View Abstract
  361. Characterization of tree allergy prevalence in children younger than 4 years. Ann Allergy Asthma Immunol. 2014 Apr; 112(4):388-9. View Abstract
  362. Perceived neighborhood safety and asthma morbidity in the school inner-city asthma study. Pediatr Pulmonol. 2015 Jan; 50(1):17-24. View Abstract
  363. Characterization of aeroallergen sensitivities in children with allergic rhinitis and chronic rhinosinusitis. Allergy Rhinol (Providence). 2014 Jan; 5(3):143-5. View Abstract
  364. ß-2 adrenergic receptor gene methylation is associated with decreased asthma severity in inner-city schoolchildren: asthma and rhinitis. Clin Exp Allergy. 2014; 44(5):681-9. View Abstract
  365. Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study. Receptors Clin Investig. 2014; 1(1). View Abstract
  366. Prevalence of and associations with allergic rhinitis in children with chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol. 2014 Feb; 78(2):343-7. View Abstract
  367. Utility of the Asthma Predictive Index in predicting childhood asthma and identifying disease-modifying interventions. Ann Allergy Asthma Immunol. 2014 Mar; 112(3):188-90. View Abstract
  368. Environmental assessment and exposure control of dust mites: a practice parameter. Ann Allergy Asthma Immunol. 2013 Dec; 111(6):465-507. View Abstract
  369. Asthma across the ages: knowledge gaps in childhood asthma. J Allergy Clin Immunol. 2014 Jan; 133(1):3-13; quiz 14. View Abstract
  370. Atopy and the Development of Chronic Rhinosinusitis in Children with Allergic Rhinitis. J Allergy Clin Immunol Pract. 2013 Nov 01; 6(1):689-691.e2. View Abstract
  371. Exposures to molds in school classrooms of children with asthma. Pediatr Allergy Immunol. 2013 Nov; 24(7):697-703. View Abstract
  372. Rethinking the prevalence of exercise-induced bronchoconstriction in patients with asthma. Ann Allergy Asthma Immunol. 2013 Dec; 111(6):567-8. View Abstract
  373. Atopy and the development of chronic rhinosinusitis in children with allergic rhinitis. J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):689-91.e1-2. View Abstract
  374. Turning up the heat on skin testing for baked egg allergy. Clin Exp Allergy. 2013 Oct; 43(10):1095-6. View Abstract
  375. Food allergy and increased asthma morbidity in a School-based Inner-City Asthma Study. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):479-84. View Abstract
  376. Predictors of indoor exposure to mouse allergen in inner-city elementary schools. Ann Allergy Asthma Immunol. 2013 Oct; 111(4):299-301.e1. View Abstract
  377. Environmental assessment and exposure reduction of cockroaches: a practice parameter. J Allergy Clin Immunol. 2013 Oct; 132(4):802-8.e1-25. View Abstract
  378. Reply: To PMID 23687635. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):543-4. View Abstract
  379. Ovomucoid is not superior to egg white testing in predicting tolerance to baked egg. J Allergy Clin Immunol Pract. 2013 Jul-Aug; 1(4):354-60. View Abstract
  380. Xenon ventilation computed tomography rules: new technology may open up further understanding in asthma. Ann Allergy Asthma Immunol. 2013 Aug; 111(2):81. View Abstract
  381. Climate change and our environment: the effect on respiratory and allergic disease. J Allergy Clin Immunol Pract. 2013 Mar; 1(2):137-41. View Abstract
  382. Environmental assessment and exposure reduction of rodents: a practice parameter. Ann Allergy Asthma Immunol. 2012 Dec; 109(6):375-87. View Abstract
  383. Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. J Allergy Clin Immunol. 2012 Nov; 130(5):1216-8. View Abstract
  384. Predicting food challenge outcomes for baked milk: role of specific IgE and skin prick testing. Ann Allergy Asthma Immunol. 2012 Nov; 109(5):309-313.e1. View Abstract
  385. The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity. J Asthma. 2012 Aug; 49(6):586-92. View Abstract
  386. Allergens in urban schools and homes of children with asthma. Pediatr Allergy Immunol. 2012 Sep; 23(6):543-9. View Abstract
  387. Role of specific IgE and skin-prick testing in predicting food challenge results to baked egg. Allergy Asthma Proc. 2012 May-Jun; 33(3):275-81. View Abstract
  388. Effect of cat and daycare exposures on the risk of asthma in children with atopic dermatitis. Allergy Asthma Proc. 2012 May-Jun; 33(3):282-8. View Abstract
  389. Endotoxin exposure in inner-city schools and homes of children with asthma. Ann Allergy Asthma Immunol. 2012 Jun; 108(6):418-22. View Abstract
  390. Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol. 2012 Apr; 108(4):223.e1-15. View Abstract
  391. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012 Mar; 148(3):391-2. View Abstract
  392. The school inner-city asthma study: design, methods, and lessons learned. J Asthma. 2011 Dec; 48(10):1007-14. View Abstract
  393. Impact of environmental controls on childhood asthma. Curr Allergy Asthma Rep. 2011 Oct; 11(5):414-20. View Abstract
  394. Agreement between parent and student responses to an asthma and allergy questionnaire in a diverse, inner-city elementary school population. Ann Allergy Asthma Immunol. 2011 Oct; 107(4):371-3. View Abstract
  395. Characterizing the relationship between sesame, coconut, and nut allergy in children. Pediatr Allergy Immunol. 2010 Dec; 21(8):1114-8. View Abstract
  396. Tree nut allergy, egg allergy, and asthma in children. Clin Pediatr (Phila). 2011 Feb; 50(2):133-9. View Abstract
  397. The effect of prophylactic palivizumab on recurrent wheezing in children with an atopic family history. J Allergy Clin Immunol. 2011 Jan; 127(1):292-3; author reply 293. View Abstract
  398. Clinically useful spirometry in preschool-aged children: evaluation of the 2007 American Thoracic Society Guidelines. J Asthma. 2010 Sep; 47(7):762-7. View Abstract
  399. The role of allergen exposure and avoidance in asthma. Adolesc Med State Art Rev. 2010 Apr; 21(1):57-71, viii-ix. View Abstract
  400. Sublingual desensitization for buprenorphine hypersensitivity. J Allergy Clin Immunol. 2010 Apr; 125(4):938-9. View Abstract
  401. Pest and allergen exposure and abatement in inner-city asthma: a work group report of the American Academy of Allergy, Asthma & Immunology Indoor Allergy/Air Pollution Committee. J Allergy Clin Immunol. 2010 Mar; 125(3):575-81. View Abstract
  402. Age-specific prevalence of outdoor and indoor aeroallergen sensitization in Boston. Clin Pediatr (Phila). 2010 Jun; 49(6):579-85. View Abstract
  403. Air filters and air cleaners: rostrum by the American Academy of Allergy, Asthma & Immunology Indoor Allergen Committee. J Allergy Clin Immunol. 2010 Jan; 125(1):32-8. View Abstract
  404. Sesame allergy: role of specific IgE and skin-prick testing in predicting food challenge results. Allergy Asthma Proc. 2009 Nov-Dec; 30(6):643-8. View Abstract
  405. Skin Testing With Water Buffalo's Milk in Children With Cow's Milk Allergy. Pediatr Asthma Allergy Immunol. 2009 Sep; 22(3):121-125. View Abstract
  406. Higher incidence of pediatric anaphylaxis in northern areas of the United States. J Allergy Clin Immunol. 2009 Oct; 124(4):850-2.e2. View Abstract
  407. The role of indoor allergens in the development of asthma. Curr Opin Allergy Clin Immunol. 2009 Apr; 9(2):128-35. View Abstract
  408. Tolerance to water buffalo milk in a child with cow milk allergy. Ann Allergy Asthma Immunol. 2009 Apr; 102(4):349. View Abstract
  409. Mouse allergens in urban elementary schools and homes of children with asthma. Ann Allergy Asthma Immunol. 2009 Feb; 102(2):125-30. View Abstract
  410. Sesame Allergy: Role of Specific IgE and Skin Prick Testing in Predicting Food Challenge Results. J Allergy Clin Immunol. 2009 Feb; 123(2 Suppl 1):S24. View Abstract
  411. Montelukast as Monotherapy for Pediatric Asthma. MP Med Prakt Pediatr. 2009; 3(63):20-23. View Abstract
  412. Cyclosporine Treatment of Intractable Colitis in Chronic Granulomatous Disease. Pediatr Asthma Allergy Immunol. 2009; 14(2):125-127. View Abstract
  413. Mouse allergen exposure, wheeze and atopy in the first seven years of life. Allergy. 2008 Nov; 63(11):1512-8. View Abstract
  414. Allergists' attitudes toward environmental control: insights into its current application in clinical practice. J Allergy Clin Immunol. 2008 Apr; 121(4):1053-4. View Abstract
  415. Prevalence and titer of IgE antibodies to mouse allergens. J Allergy Clin Immunol. 2007 Nov; 120(5):1058-64. View Abstract
  416. Sensitization to mouse allergen and asthma and asthma morbidity among women in Boston. J Allergy Clin Immunol. 2007 Oct; 120(4):954-6. View Abstract
  417. Environmental factors and childhood asthma. Pediatr Ann. 2006 Sep; 35(9):646-56. View Abstract
  418. Assessment of adrenal suppression in children with asthma treated with inhaled corticosteroids: use of dehydroepiandrosterone sulfate as a screening test. Ann Allergy Asthma Immunol. 2006 Aug; 97(2):182-6. View Abstract
  419. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children. Ann Allergy Asthma Immunol. 2006 May; 96(5):701-6. View Abstract
  420. Treatment of glenoid loosening and bone loss due to osteolysis with glenoid bone grafting. J Shoulder Elbow Surg. 2006 Jan-Feb; 15(1):84-7. View Abstract
  421. Allergens of animal and biological systems Chapter 12. Fleming DO, Hunt DL, editors. Biological safety: principles and practices. 2006. View Abstract
  422. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005 Oct; 24(5):839-47. View Abstract
  423. Predictors of indoor exposure to mouse allergen in urban and suburban homes in Boston. Allergy. 2005 May; 60(5):697-701. View Abstract
  424. Allergic rhinoconjunctivitis: epidemiology. Immunol Allergy Clin North Am. 2005 May; 25(2):263-81, vi. View Abstract
  425. Mouse exposure and wheeze in the first year of life. Ann Allergy Asthma Immunol. 2005 May; 94(5):593-9. View Abstract
  426. Low-normal gestational age as a predictor of asthma at 6 years of age. Pediatrics. 2004 Sep; 114(3):e327-32. View Abstract
  427. Endotoxin exposure and eczema in the first year of life. Pediatrics. 2004 Jul; 114(1):13-8. View Abstract
  428. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol. 2004 Apr; 92(4):420-5. View Abstract
  429. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids. Ann Allergy Asthma Immunol. 2003 Jul; 91(1):49-54. View Abstract
  430. Churg-Strauss syndrome in a 7-year-old receiving montelukast and inhaled corticosteroids. Ann Allergy Asthma Immunol. 2003 Feb; 90(2):274. View Abstract
  431. Environmental indoor allergens. Pediatr Ann. 2003 Jan; 32(1):40-8. View Abstract
  432. Rodent allergens. Curr Allergy Asthma Rep. 2002 Sep; 2(5):412-6. View Abstract
  433. The efficacy of montelukast in the treatment of cat allergen-induced asthma in children. J Allergy Clin Immunol. 2002 May; 109(5):794-9. View Abstract
  434. Animal allergens and their control. Curr Allergy Asthma Rep. 2001 Sep; 1(5):461-5. View Abstract
  435. Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency. Clin Infect Dis. 2001 Jan; 32(1):E13-4. View Abstract
  436. Mouse allergen. I. The prevalence of mouse allergen in inner-city homes. The National Cooperative Inner-City Asthma Study. J Allergy Clin Immunol. 2000 Dec; 106(6):1070-4. View Abstract
  437. Mouse allergen. II. The relationship of mouse allergen exposure to mouse sensitization and asthma morbidity in inner-city children with asthma. J Allergy Clin Immunol. 2000 Dec; 106(6):1075-80. View Abstract
  438. A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge. J Allergy Clin Immunol. 2000 Apr; 105(4):704-10. View Abstract
  439. Vomiting and syncope in a 14-year-old female. Ann Allergy Asthma Immunol. 2000 Mar; 84(3):290-3. View Abstract
  440. “Cross-reactivity between sulfonamides and loop or thiazide diuretics: Is it a theoretical or actual risk?”. Allergy Clin Immunol International. 2000; 12:26-28. View Abstract
  441. Cyclosporine treatment of intractable colitis in chronic granulomatous disease. Pediatr Asthma Allergy Immunol. 2000; 14(2):125-8. View Abstract
  442. Allergens of animal and biological systems. Fleming DO, Hunt DL, editors. Biological safety: principles and practices. 2000; 249-59. View Abstract
  443. Cross-Reactivity Between Sulfonamides and Loop or Thiazide Diuretics: Is it a Theoretical or Actual Risk? Allergy Clin Immunol Int. 2000; 12(1):26-28. View Abstract
  444. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol. 1999 May; 103(5 Pt 1):773-9. View Abstract
  445. The value of acoustic rhinometry in assessing nasal responses to cat exposure. J Allergy Clin Immunol. 1998 Dec; 102(6 Pt 1):896-901. View Abstract
  446. The fallacy of evaluating biomaterial wear-rates with water as lubricant: a hip simulator study of alumina-PTFE nd CoCr-PTFE combinations. J Biomed Mater Res. 1998 Feb; 39(2):229-33. View Abstract

Contact Wanda Phipatanakul

Print Profile